Search

Author/Creator Erlanson, Martin

1. Cell‐of‐origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B‐cell lymphoma. Issue 1 (7th November 2019)

Authors:
Abdulla, Maysaa; Hollander, Peter; Pandzic, Tatjana; Mansouri, Larry; Ednersson, Susanne Bram; Andersson, Per‐Ola; Hultdin, Magnus; Fors, Maja; Erlanson, Martin; Degerman, Sofie; Petersen, Helga Munch; Asmar, Fazila; Grønbæk, Kirsten; Enblad, Gunilla; Cavelier, Lucia; Rosenquist, Richard; Amini, ...
Journal:
American journal of hematology
Issue:
Volume 95:Issue 1(2020:Jan.)
Page Start:
57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical characteristics, therapy response, and outcome of 51 adult patients with hematological malignancy-associated hemophagocytic lymphohistiocytosis: a single institution experience. Issue 8 (3rd August 2018)

Authors:
Lorenz, Fryderyk; Klimkowska, Monika; Pawłowicz, Ewa; Bulanda Brustad, Agnes; Erlanson, Martin; Machaczka, Maciej
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 8(2018)
Page Start:
1840
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy. (14th October 2019)

Authors:
Lagerlöf, Ingemar; Holte, Harald; Glimelius, Ingrid; Björkholm, Magnus; Enblad, Gunilla; Erlanson, Martin; Fluge, Øystein; Fohlin, Helena; Fosså, Alexander; Goldkuhl, Christina; Gustavsson, Anita; Johansson, Ann‐Sofie; Linderoth, Johan; Nome, Ole; Palma, Marzia; Åkesson, Lisa; Østenstad, Bjørn; R...
Journal:
British journal of haematology
Issue:
Volume 188:Number 5(2020)
Page Start:
685
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas. Issue 9 (2nd September 2015)

Authors:
Kimby, Eva; Östenstad, Björn; Brown, Peter; Hagberg, Hans; Erlanson, Martin; Holte, Harald; Linden, Ola; Johansson, Ann-Sofie; Ahlgren, Tomas; Wader, Karin; Wahlin, Björn Engelbrekt; Delabie, Jan; Sundström, Christer
Journal:
Leukemia & lymphoma
Issue:
Volume 56:Issue 9(2015:Sep.)
Page Start:
2598
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗